# Biological Characteristics of a Probiotic Wickerhamomyces anomalus Isolated from Pickled Vegetables and Its Function in Preventing Hyperuricemia in Mice

**Authors:** Xiqian Tan, Shuaibo Gao, Xiaoxiao Cheng, Lijun You, Xuepeng Li, Jianrong Li

PMC · DOI: 10.3390/foods15040744 · 2026-02-18

## TL;DR

A probiotic yeast from pickled vegetables was found to lower uric acid in mice, suggesting it could help prevent gout and kidney disease.

## Contribution

The study identifies Wickerhamomyces anomalus YFJ252 as a novel probiotic with uric acid-lowering effects and potential anti-HUA mechanisms.

## Key findings

- YFJ252 showed strong in vitro xanthine oxidase inhibition and antioxidant activity.
- Mice fed YFJ252 had significantly lower serum uric acid, creatinine, and urea nitrogen levels.
- Genome and metabolomics analyses suggest YFJ252 may use purine-degrading pathways to combat hyperuricemia.

## Abstract

Hyperuricemia (HUA) is a metabolic disorder that can easily lead to gout or kidney disease, and it is believed that it can be treated effectively using probiotics. This study evaluated the safety, probiotic, and functional properties of Wickerhamomyces anomalus YFJ252, isolated from pickled vegetables, including its in vitro inhibitory activity against xanthine oxidase (XO) and in vivo uric acid-lowering activity in mice, using virulence factor screening, plate counting, and colorimetric assays. Meanwhile, the potential anti-HUA mechanism was also investigated using untargeted metabolomics and whole-genome analysis. The results show that YFJ252 is non-hemolytic and does not produce DNase, gelatinase, or biogenic amine. It has potential probiotic properties: 85.83% DPPH radical scavenging, 39.94% α-amylase inhibition, 35.32% α-glucosidase inhibition, 20.73% anti-inflammatory ability, and 84.15% XO inhibition capacity. Animal experiments indicated that early intake of YFJ252 could maintain serum uric acid levels at 165.08 μmol/L (p < 0.05), lower than the HUA group (212.19 μmol/L), and significantly decrease creatinine and urea nitrogen levels (p < 0.05). The hypothetical anti-HUA potential of YFJ252 might be due to the production of antioxidant, hypoglycemic, and XO-inhibitory metabolites during growth, as well as a purine-degrading pathway that the strain inherited. This study provides a theoretical basis for using W. anomalus YFJ252 as a food ingredient with preventive effects against HUA.

## Linked entities

- **Chemicals:** uric acid (PubChem CID 1175), creatinine (PubChem CID 588), urea nitrogen (PubChem CID 31295)
- **Diseases:** hyperuricemia (MONDO:0002144), gout (MONDO:0005393), kidney disease (MONDO:0001343)
- **Species:** Wickerhamomyces anomalus (taxon 4927), Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** AHP1 (thioredoxin peroxidase AHP1) [NCBI Gene 850799], GUD1 (guanine deaminase) [NCBI Gene 851360], HSP12 (lipid-binding protein HSP12) [NCBI Gene 850532] {aka GLP1, HOR5}, DAL1 (allantoinase) [NCBI Gene 854845], DAL2 (allantoicase) [NCBI Gene 854847] {aka ALC1}, PNP1 (purine-nucleoside phosphorylase) [NCBI Gene 850906]
- **Diseases:** HUA (MESH:D033461), intestinal diseases (MESH:D007410), liver and kidney damage (MESH:D056486), allergic reactions (MESH:D004342), kidney disease (MESH:D007674), IR (MESH:D007333), infection (MESH:D007239), renal tubular injury (MESH:D015499), Hemolytic (MESH:D006461), metabolic disorder (MESH:D008659), hypoglycemic (MESH:C000721848), Desulfovibrionaceae (MESH:D045824), prediabetes (MESH:D011236), diabetes (MESH:D003920), mitochondrial dysfunction (MESH:D028361), gout (MESH:D006073), injury to (MESH:D014947), Inflammation (MESH:D007249), interstitial fibrosis (MESH:D005355)
- **Chemicals:** Cr (MESH:D003404), organic compounds (MESH:D009930), ribose (MESH:D012266), glucose (MESH:D005947), chloramphenicol (MESH:D002701), SCFA (MESH:D005232), threonine (MESH:D013912), benzbromarone (MESH:D001553), ice (MESH:D007053), acetate (MESH:D000085), Lys (MESH:D008239), sphingolipid (MESH:D013107), PBS (MESH:D007854), Trp (MESH:D014364), Guanosine (MESH:D006151), LPS (MESH:D008070), ammonium acetate (MESH:C018824), ABTS (MESH:C002502), lipid (MESH:D008055), purine (MESH:C030985), ammonium hydroxide (MESH:D064753), Agarose (MESH:D012685), Na2CO3 (MESH:C005686), ampicillin (MESH:D000667), fructose (MESH:D005632), pantothenic acid (MESH:D010205), CO2 (MESH:D002245), phenylpropane (MESH:C024268), glutathione (MESH:D005978), shikimic acid (MESH:D012765), coenzyme A (MESH:D003065), Amine (MESH:D000588), propionate (MESH:D011422), starch (MESH:D013213), phenylalanine (MESH:D010649), serine (MESH:D012694), phenols (MESH:D010636), Vc (MESH:C098534), K2S2O8 (MESH:C009007), Arginine (MESH:D001120), fatty acids (MESH:D005227), carbohydrate (MESH:D002241), phenanthroline (MESH:D010618), aspartate (MESH:D001224), urea (MESH:D014508), amino acid (MESH:D000596), penicillin (MESH:D010406), tetracycline (MESH:D013752), H2O2 (MESH:D006861), ethyl acetate (MESH:C007650), CaCl3 (-), DNS (MESH:C022306), febuxostat (MESH:D000069465), sulfur (MESH:D013455), Bile Salts (MESH:D001647), ethanol (MESH:D000431), polyketide (MESH:D061065), xanthine (MESH:D019820), kanamycin (MESH:D007612), dicarboxylic acid (MESH:D003998)
- **Species:** gut metagenome (species) [taxon 749906], Limosilactobacillus reuteri (species) [taxon 1598], Torulaspora delbrueckii (species) [taxon 4950], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Staphylococcus aureus (species) [taxon 1280], Leptospira sp. AB (species) [taxon 103236], Bacteroides (genus) [taxon 816], Ruminococcus (genus) [taxon 1263], [Clostridium] innocuum (species) [taxon 1522], Hafnia (genus) [taxon 568], Wickerhamomyces silvicola (species) [taxon 36029], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Wickerhamomyces anomalus (species) [taxon 4927], Hanseniaspora uvarum (species) [taxon 29833], Prevotella (genus) [taxon 838], Mus musculus (house mouse, species) [taxon 10090], Leuconostoc mesenteroides (species) [taxon 1245], Escherichia coli (E. coli, species) [taxon 562]
- **Cell lines:** YFJ252 — Homo sapiens (Human), Malignant neoplasm of multiple primary sites, Transformed cell line (CVCL_EP97)

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939893/full.md

---
Source: https://tomesphere.com/paper/PMC12939893